Tag #Curevac

Showing 1 to 2 of 2 results

welt.de
🌐 85% Global Worthiness
News related image

BioNTech to Acquire CureVac, Boosting Tübingen's Biotech Hub

BioNTech, a Mainz-based pharmaceutical company, plans to acquire its Tübingen-based rival CureVac in a multi-billion euro deal, aiming to expand mRNA-based cancer immunotherapy research and development in Tübingen, strengthening the region's biotech hub and securing high-skilled jobs.

Progress

44% Bias Score

Decent Work and Economic Growth
dw.com
🌐 85% Global Worthiness
News related image

BioNTech to Acquire Curevac for $1.25 Billion

BioNTech, co-founded by Prof. Ugur Sahin and Prof. Ozlem Tureci, will acquire Curevac for $1.25 billion, strengthening its mRNA cancer treatments, with the deal expected to close by late 2025, combining their expertise in mRNA technology.

Progress

32% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results